October 2022 Medical News Summary

Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training Related Content:

• Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions
• Treating Cancer in Pregnant Patients After Roe v Wade Overturned
• Dobbs Decision Threatens Full Breadth of Ob-Gyn Training